BioSpace News Archive

50 Years of Biotechnology Innovations: PMI’s Top 10 Impactful Biotech Projects

The Project Management Institute announced its Most Influential Projects list. The list has some of the best biotechnology innovations that took place in recent years.

October 8, 2019
·
7 min read
·
Mark Terry
Employer Resources

How to Identify a Quality Life Sciences Candidate

Here are some criteria used to identify the highest-quality life sciences candidates and some insight on how you can pick the cream of the crop for your organization.

October 8, 2019
·
4 min read
·
Porschia Parker
FDA

Novartis’ Wet AMD Drug Wins FDA Approval

The approval of Beovu was based on findings from the Phase III HAWK and HARRIER clinical trials, in which Novartis’ drug demonstrated non-inferiority versus Eylea in mean change in best-corrected visual acuity at 48 weeks.

October 8, 2019
·
2 min read
·
Alex Keown
Santhera Announces Presentation by ReveraGen of Positive 18-Month Data with Vamorolone in Duchenne Muscular Dystrophy

Santhera Pharmaceuticals announces presentation of data showing continued improvement of muscle function and improved tolerability compared with corticosteroids of 18-month vamorolone treatment in Duchenne muscular dystrophy.

October 8, 2019
·
7 min read
Sensyne Health signs major agreements with a Fortune 200 healthcare company and a data infrastructure specialist to launch and scale its digital health products in the U.S.

Sensyne Health plc, the British clinical AI technology company, announced it has signed agreements with a Fortune 200 company and a data infrastructure specialist to launch and scale its digital health products under licence in the U.S.

October 8, 2019
·
3 min read
Policy

Biom’up announces the approval of HEMOBLASTTM Bellows and its laparoscopic applicator in Australia

Successful review of HEMOBLAST Bellows’ performance and safety profile as well as Biom’up’s Quality Management System by the Australian Therapeutic Goods Administration (TGA)

October 8, 2019
·
5 min read
Pharm Country

Castor Announces International Expansion to Meet Growing Demand for AI-Powered Clinical Data Platform

Amsterdam, The Netherlands and Hoboken, New Jersey, USA, October 7, 2019: Castor, a health-tech company that helps medical researchers maximize the value of research data, announces its international business expansion.

October 8, 2019
·
3 min read
Deals

MiroBio launches with £27m ($34m) Series A from leading life sciences investors

Oxford start-up developing novel therapeutics based on deep expertise in immune cell regulation

October 8, 2019
·
3 min read
Drug Development

Summit Therapeutics Reports New Data from Phase 2 Clinical Trial Connecting Ridinilazole’s Microbiome Preservation to Improved Clinical Outcomes for Patients with C. difficile Infection

Summit Therapeutics plc announced the presentation of new data that explain the link between two key findings in the Company’s Phase 2 clinical trial of ridinilazole for C. difficile infection

October 8, 2019
·
7 min read
Business

Akcea and Pfizer Inc. Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-LRx

Akcea and Ionis to earn $250 million license fee

October 8, 2019
·
9 min read